3 completed, 2 terminated. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 3, Terminated 2 |
Follow Paroxysmal Supraventricular Tachycardia: new trials by email Literature Review of Paroxysmal Supraventricular Tachycardia trials Research Report on Paroxysmal Supraventricular Tachycardia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia Etripamil NS 70 mg, Placebo - Tachycardia, Supraventricular, Paroxysmal Supraventricular Tachycardia | Phase 3 | Completed | Corxel Pharmaceuticals | 500 | 2022-06-30 | 2026-11-02 |
| Etripamil Nasal Spray in Patients With Paroxysmal Supraventricular Tachycardia Etripamil NS 70 mg, Aptar Pharma Nasal Spray Bidose System - Paroxysmal Supraventricular Tachycardia | Phase 3 | Completed | Milestone Pharmaceuticals Inc. | 130 | 2021-12-13 | 2026-05-15 |
| Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303 Etripamil NS - Paroxysmal Supraventricular Tachycardia | Phase 3 | Completed | Milestone Pharmaceuticals Inc. | 1116 | 2019-09-23 | 2024-05-23 |
| Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302 Etripamil NS 70 mg, Aptar Pharma Nasal Spray Bidose System - Paroxysmal Supraventricular Tachycardia | Phase 3 | Terminated | Milestone Pharmaceuticals Inc. | 169 | 2018-12-10 | 2024-11-05 |
| Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT). Etripamil, Placebo, Etripamil Test Dose - Paroxysmal Supraventricular Tachycardia | Phase 3 | Terminated | Milestone Pharmaceuticals Inc. | 1097 | 2018-06-18 | 2024-07-12 |
Tachycardia, Ventricular (5) · Tachycardia, Atrioventricular Nodal Reentry (2) · Tachycardia, Supraventricular (1)
Arrhythmias, Cardiac (5) · Cardiac Conduction System Disease (5) · Cardiovascular Diseases (5) · Heart Diseases (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Tachycardia (5) · Tachycardia, Reciprocating (2)
etripamil (1)
Milestone Pharmaceuticals Inc. (4) · Corxel Pharmaceuticals (1)
Canada (4) · United States (4) · Argentina (1) · Belgium (1) · Brazil (1) · China (1) · Colombia (1) · France (1) · Germany (1) · Hungary (1) · Netherlands (1) · Poland (1) · Spain (1)
Changsheng Ma (1) · David Bharucha, MD (1) · Francis Plat, MD (1) · Xiaowen Chen (1)
PMID 35728658, PMID 36441560, PMID 37331368, PMID 37753718, PMID 40931676, PMID 41668514
2018 (1)